Please login to the form below

Not currently logged in
Email:
Password:

treatment access

This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.

AbbVie sues NHS England over hep C procurement

AbbVie sues NHS England over hep C procurement

While the decline in deaths suggests more people are getting access to drug treatment, PHE said more needs to be done, and it urged “anyone who has ever injected drugs, even ... Meanwhile, HCV Elimination Days being held in some areas to bring together

Latest news

  • NICE says no to AZ and Vifor’s rival hyperkalaemia drugs NICE says no to AZ and Vifor’s rival hyperkalaemia drugs

    Most common in patients with poor kidney function, heart failure or liver disease, hyperkalemia can be fatal, and patients have had few options for treatment until now. ... hyperkalaemia can access the treatment.

  • Allogene raises $324m from record-breaking IPO for off-the shelf CAR-Ts Allogene raises $324m from record-breaking IPO for off-the shelf CAR-Ts

    allogeneic cell therapy and the potential for greater and faster patient access, ”said Belldegrun. ... Pfizer also has a 25% stake in the company, allowing Allogene access to a portfolio of treatment options, including gene editing technology.

  • Janssen’s single tablet Symtuza gains NHS England funding  Janssen’s single tablet Symtuza gains NHS England funding 

    2014. “We are delighted that NHSE has provided vital funding for this treatment option; enabling access for individuals who require a darunavir-based STR to effectively control their HIV, with the ... potential to support adherence to treatment,

  • Saatchi and Saatchi Wellness London launch IVF campaign Saatchi and Saatchi Wellness London launch IVF campaign

    Saatchi and Saatchi Wellness London launch IVF campaign. The advertising agency targets fair access to IVF treatments. ... The new campaign targets fair access to IVF treatments in the UK, where 3.5 million people are affected by fertility issues, but

  • NICE U-turn on Crystiva for rare bone disease NICE U-turn on Crystiva for rare bone disease

    This marks a step change in treatment for XLH, emphasised through the emotional testimonies provided by patient groups and clinicians following the first evaluation consultation.”. ... Access to a treatment that tackles the underlying mechanism and has

More from news
Approximately 1 fully matching, plus 207 partially matching documents found.

Latest Intelligence

  • Patient outcomes in practice: delivering value that transforms lives Patient outcomes in practice: delivering value that transforms lives

    It means we have to think big in designing programmes. We must understand how we can affect the system and improve decision-making, information, access, monitoring and treatment transitions. ... making, information, access, monitoring and treatment

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    Take a recent local NHS partnership aimed at addressing specific access and capacity issues in Southampton. ... to essential treatment, expanding and improving care for people living with a leading cause of vision loss – age-related macular

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    Simplifying HCP access to digital information. New industry-standards group launched. The life science industry’s commercial model has transformed significantly over the past decade. ... This new standard will improve how life science companies

  • The gold standard of scientific evidence The gold standard of scientific evidence

    By randomising access to the treatment, researchers would be able to measure efficacy using robust statistical methods. ... Even social media data can be used to measure real-world treatment safety and effectiveness.

  • The real-world data conundrum The real-world data conundrum

    treatment options, access for populations in developing countries and an up-to-date evidence-base is ever increasing. ... when healthcare professionals will be able to provide the right treatment, for the right person, at the right dose, at the right time

More from intelligence
Approximately 1 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics